![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Departments of
*
Nutrition and
Mental Health and Alcohol Research (Research Unit of Substance Abuse), National Public Health Institute (KTL), Mannerheimintie 166 F, FIN-00300 Helsinki, Finland
2To whom correspondence should be addressed. E-mail: iris.erlund{at}ktl.fi
The flavanones naringenin and hesperetin exhibit estrogenic, anticarcinogenic and antioxidative properties. Orange juice and grapefruit juice contain high amounts of these compounds, and therefore their intake from the diet can be relatively high. No data are available regarding plasma concentrations or plasma kinetics of flavanones. The objectives of this study were to develop methods allowing the analysis of naringenin and hesperetin from plasma and urine and to study their plasma kinetics and urinary excretion. We also wanted to assess whether plasma or urine flavanone concentrations can be used as biomarkers of intake. Healthy volunteers ingested orange juice (five women and three men) or grapefruit juice (two women and three men) once (8 mL/kg). Eleven blood samples and urine were collected between 0 and 24 h after juice administration. Flavanones were analyzed by HPLC with electrochemical detection. Naringenin and hesperetin were bioavailable from the studied juices, but interindividual variation in bioavailability was remarkable. The resulting plasma concentrations were comparatively high, and the peak plasma concentrations (Cmax) were 0.6 ± 0.4 µmol/L (means ± SD) for naringenin from orange juice and 6.0 ± 5.4 µmol/L for naringenin from grapefruit juice. The corresponding value for hesperetin from orange juice was 2.2 ± 1.6 µmol/L. The elimination half-lives were between 1.3 and 2.2 h, and therefore plasma concentrations reflect short-term intake. The relative urinary excretion varied depending on the flavanone source and dose and was 30.2 ± 25.5% and 1.1 ± 0.8% for naringenin from grapefruit juice and orange juice, respectively, and 5.3 ± 3.1% for hesperetin from orange juice. The considerable difference in the relative urinary excretion of naringenin from the two juices was most likely caused by dose-dependent renal clearance rather than differences in bioavailability (as indicated by the similar Cmax-to-dose ratios). The results indicate that urine flavanone concentrations are not good biomarkers of dietary intake. We conclude that because of the relatively high concentrations of flavanones in plasma after ingestion of orange juice or grapefruit juice, considerable health effects could ensue in individuals consuming them regularly.
KEY WORDS: • flavonoids • naringenin • hesperetin • kinetics • bioavailability • humans
This article has been cited by other articles:
|
|
 |
|
  B. Morin, L. A. Nichols, K. M. Zalasky, J. W. Davis, J. A. Manthey, and L. J. Holland The Citrus Flavonoids Hesperetin and Nobiletin Differentially Regulate Low Density Lipoprotein Receptor Gene Transcription in HepG2 Liver Cells J. Nutr., July 1, 2008; 138(7): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nanua, S. M. Zick, J. E. Andrade, U. S. Sajjan, J. R. Burgess, N. W. Lukacs, and M. B. Hershenson Quercetin Blocks Airway Epithelial Cell Chemokine Expression Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 602 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Greenblatt, R. A. Leigh-Pemberton, and L. L. von Moltke In Vitro Interactions of Water-Soluble Garlic Components with Human Cytochromes P450 J. Nutr., March 1, 2006; 136(3): 806S - 809S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. F. Nielsen, W. S. S. Chee, L. Poulsen, E. Offord-Cavin, S. E. Rasmussen, H. Frederiksen, M. Enslen, D. Barron, M.-N. Horcajada, and G. Williamson Bioavailability Is Improved by Enzymatic Modification of the Citrus Flavonoid Hesperidin in Humans: A Randomized, Double-Blind, Crossover Trial J. Nutr., February 1, 2006; 136(2): 404 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells Exp Biol Med, September 1, 2005; 230(8): 558 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zitron, E. Scholz, R. W. Owen, S. Luck, C. Kiesecker, D. Thomas, S. Kathofer, F. Niroomand, J. Kiehn, V. A.W. Kreye, et al. QTc Prolongation by Grapefruit Juice and Its Potential Pharmacological Basis: HERG Channel Blockade by Flavonoids Circulation, February 22, 2005; 111(7): 835 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bagli, M. Stefaniotou, L. Morbidelli, M. Ziche, K. Psillas, C. Murphy, and T. Fotsis Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3'-Kinase Activity Cancer Res., November 1, 2004; 64(21): 7936 - 7946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brevik, S. E. Rasmussen, C. A. Drevon, and L. F. Andersen Urinary Excretion of Flavonoids Reflects Even Small Changes in the Dietary Intake of Fruits and Vegetables Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 843 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Harris, D. M. Wood, L. Bottomley, S. Blagg, K. Owen, P. J. Hughes, R. H. Waring, and C. J. Kirk Phytoestrogens Are Potent Inhibitors of Estrogen Sulfation: Implications for Breast Cancer Risk and Treatment J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1779 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Krogholm, J. Haraldsdottir, P. Knuthsen, and S. E. Rasmussen Urinary Total Flavonoid Excretion but Not 4-Pyridoxic Acid or Potassium Can Be Used as a Biomarker for the Intake of Fruits and Vegetables J. Nutr., February 1, 2004; 134(2): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sanchez-Moreno, M P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans Am. J. Clinical Nutrition, September 1, 2003; 78(3): 454 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans J. Nutr., July 1, 2003; 133(7): 2204 - 2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Felgines, S. Talavera, M.-P. Gonthier, O. Texier, A. Scalbert, J.-L. Lamaison, and C. Remesy Strawberry Anthocyanins Are Recovered in Urine as Glucuro- and Sulfoconjugates in Humans J. Nutr., May 1, 2003; 133(5): 1296 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bugianesi, G. Catasta, P. Spigno, A. D'Uva, and G. Maiani Naringenin from Cooked Tomato Paste Is Bioavailable in Men J. Nutr., November 1, 2002; 132(11): 3349 - 3352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Nielsen, R. Freese, P. Kleemola, and M. Mutanen Flavonoids in Human Urine as Biomarkers for Intake of Fruits and Vegetables Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 459 - 466. [Abstract] [Full Text] [PDF]
|
|
